-
Something wrong with this record ?
Native high-density lipoprotein and melatonin improve platelet response induced by glycated lipoproteins
D. Ozsavci, A. Nazli, O. Bingol Ozakpinar, G. Yanikkaya Demirel, B. Vanizor Kural, A. Sener
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Apoptosis drug effects MeSH
- Aryldialkylphosphatase metabolism MeSH
- Adult MeSH
- Glutathione metabolism MeSH
- Glycosylation drug effects MeSH
- Protein Carbonylation MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipoproteins, HDL pharmacology MeSH
- Malondialdehyde metabolism MeSH
- Melatonin pharmacology MeSH
- Nitric Oxide metabolism MeSH
- Oxidation-Reduction MeSH
- Oxidative Stress drug effects MeSH
- Blood Platelets drug effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
Activated platelets and glycated lipoproteins are responsible for atherothrombosis in diabetics. Melatonin and native high-density lipoproteins are crucial in the preservation of pro/oxidant-antioxidant balance. The aim of the present study was to investigate the in vitro effects of native high-density lipoproteins and melatonin on altering the platelet response induced by glycated lipoproteins. Low-density lipoproteins and high-density lipoproteins were purified from plasma by ultracentrifugation and were glycated with glucose for three weeks. After incubation with or without melatonin/or native highdensity lipoproteins, low-density lipoproteins, glycated low-density lipoproteins/glycated high-density lipoproteins were added to ADP-induced platelets. Oxidative parameters, caspase-3/9 and nitric oxide levels were measured spectrophotometrically; CD62-P/ annexin-V expression was determined by flow cytometry. In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, platelet malondialdehyde/ protein carbonyl, P-selectin, annexin-V, caspase-3/9 levels were increased (ranging from P < 0.001 to P < 0.01); glutathione and nitric oxide levels were reduced (ranging from P < 0.001 to P < 0.01). In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, melatonin treatment reduced malondialdehyde, protein carbonyl, CD62-P, annexin-V and caspase-3/9 (P < 0.001, P < 0.01) levels and elevated nitric oxide (only glycated low-density lipoproteins). In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, native high-density lipoprotein treatment reduced malondialdehyde, protein carbonyl, annexin-V, caspase-3/9 levels (P < 0.001, P < 0.01) and increased glutathione; nitric oxide levels (only with gly-HDL). Both melatonin and high-density lipoproteins should be regarded as novel promising mechanism-based potential therapeutic targets to prevent atherothrombosis in diabetics.
Department of Biochemistry Faculty of Pharmacy Marmara University İstanbul Turkey
Department of Biochemistry Medical Faculty Karadeniz Technical University Trabzon Turkey
Department of Immunology School of Medicine Yeditepe University İstanbul Turkey
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19021848
- 003
- CZ-PrNML
- 005
- 20190614075942.0
- 007
- ta
- 008
- 190607s2018 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)30724160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Ozsavci, D. $u Department of Biochemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
- 245 10
- $a Native high-density lipoprotein and melatonin improve platelet response induced by glycated lipoproteins / $c D. Ozsavci, A. Nazli, O. Bingol Ozakpinar, G. Yanikkaya Demirel, B. Vanizor Kural, A. Sener
- 520 9_
- $a Activated platelets and glycated lipoproteins are responsible for atherothrombosis in diabetics. Melatonin and native high-density lipoproteins are crucial in the preservation of pro/oxidant-antioxidant balance. The aim of the present study was to investigate the in vitro effects of native high-density lipoproteins and melatonin on altering the platelet response induced by glycated lipoproteins. Low-density lipoproteins and high-density lipoproteins were purified from plasma by ultracentrifugation and were glycated with glucose for three weeks. After incubation with or without melatonin/or native highdensity lipoproteins, low-density lipoproteins, glycated low-density lipoproteins/glycated high-density lipoproteins were added to ADP-induced platelets. Oxidative parameters, caspase-3/9 and nitric oxide levels were measured spectrophotometrically; CD62-P/ annexin-V expression was determined by flow cytometry. In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, platelet malondialdehyde/ protein carbonyl, P-selectin, annexin-V, caspase-3/9 levels were increased (ranging from P < 0.001 to P < 0.01); glutathione and nitric oxide levels were reduced (ranging from P < 0.001 to P < 0.01). In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, melatonin treatment reduced malondialdehyde, protein carbonyl, CD62-P, annexin-V and caspase-3/9 (P < 0.001, P < 0.01) levels and elevated nitric oxide (only glycated low-density lipoproteins). In glycated low-density lipoprotein/glycated high-density lipoprotein-treated groups, native high-density lipoprotein treatment reduced malondialdehyde, protein carbonyl, annexin-V, caspase-3/9 levels (P < 0.001, P < 0.01) and increased glutathione; nitric oxide levels (only with gly-HDL). Both melatonin and high-density lipoproteins should be regarded as novel promising mechanism-based potential therapeutic targets to prevent atherothrombosis in diabetics.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a aryldialkylfosfatasa $x metabolismus $7 D043303
- 650 _2
- $a trombocyty $x účinky léků $7 D001792
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a glykosylace $x účinky léků $7 D006031
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipoproteiny HDL $x farmakologie $7 D008075
- 650 _2
- $a malondialdehyd $x metabolismus $7 D008315
- 650 _2
- $a melatonin $x farmakologie $7 D008550
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a karbonylace proteinů $7 D050050
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nazli, A. $u Department of Biochemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
- 700 1_
- $a Bingol Ozakpinar, O. $u Department of Biochemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
- 700 1_
- $a Yanikkaya Demirel, G. $u Department of Immunology, School of Medicine, Yeditepe University, İstanbul, Turkey
- 700 1_
- $a Vanizor Kural, B. $u Department of Biochemistry, Medical Faculty, Karadeniz Technical University, Trabzon, Turkey
- 700 1_
- $a Sener, A. $u Department of Biochemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 64, č. 4 (2018), s. 144-152
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30724160 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/5879/fb2018a0018.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20190607 $b ABA008
- 991 __
- $a 20190614080130 $b ABA008
- 999 __
- $a ok $b bmc $g 1415463 $s 1060203
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 64 $c 4 $d 144-152 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20190607